SATIV
DEAD

Serial Number

79357378

Owner

CNX THERAPEUTICS LIMITED

Attorney

Michael T. Olsen

Filing Date

Nov 16, 2022

Add to watchlist:

No watchlists yet
View on USPTO

SATIV Trademark

Serial Number: 79357378

SATIV is a trademark filed by CNX THERAPEUTICS LIMITED on November 16, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

CNX THERAPEUTICS LIMITED (3 trademarks)

3 BUNHILL ROW
LONDON EC1Y 8YZ , GB

Entity Type: 24

GW Pharma Limited (40 trademarks)

Sovereign House, Histon

Entity Type: 03

Jazz Pharmaceuticals Research UK Limited (46 trademarks)

Building 730,

Entity Type: 98

Trademark Details

Filing Date

November 16, 2022

Registration Date

Not Registered

Goods & Services

Pharmaceutical and veterinary preparations for use in treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for use in treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; pure extracts of medicinal plants and herbs; foodstuffs for medicinal purposes, namely, dietetic foods adapted for medical use; herb teas for medicinal purposes

Filing History

CHANGE OF OWNER RECEIVED FROM IB
Mar 5, 2026 CHLD
CHANGE OF OWNER RECEIVED FROM IB
Feb 5, 2026 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 18, 2025 FINT
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 18, 2025 ADCH
FINAL DISPOSITION NOTICE SENT TO IB
Nov 20, 2025 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 20, 2025 FICR
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Nov 20, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 20, 2024 ABN2
REFUSAL PROCESSED BY IB
Jun 2, 2024 RFNT
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 27, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 8, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 8, 2024 OPNR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 26, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 26, 2024 GNRT
NON-FINAL ACTION WRITTEN
Apr 26, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 26, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 26, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 26, 2024 TROA
REFUSAL PROCESSED BY IB
Oct 16, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 26, 2023 RFCS
REFUSAL PROCESSED BY MPU
Sep 26, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 8, 2023 RFCR
NON-FINAL ACTION WRITTEN
Sep 7, 2023 CNRT
ASSIGNED TO EXAMINER
Aug 30, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 16, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 12, 2022 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Dec 8, 2022 SDRC